Not Yet RecruitingNot Applicable

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

South Korea60 participantsStarted 2025-06

Plain-language summary

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults aged 19 years or older at the time of screening * Patients diagnosed with diverticular bleeding Exclusion Criteria: * Patients diagnosed with upper gastrointestinal bleeding

What they're measuring

Rebleeding rate

Timeframe: 30 days post treatment

Trial details

NCT IDNCT06939907

SponsorNext Biomedical Co., Ltd.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2027-06

View on ClinicalTrials.gov More Lower Gastrointestinal Bleeding trials